NO20025107D0 - Diacabicykliske sentralnervesystemaktive midler - Google Patents

Diacabicykliske sentralnervesystemaktive midler

Info

Publication number: NO20025107D0
Authority: NO; Norway
Prior art keywords: diacabicyclic; nervous system; active agents; central nervous; system active
Prior art date: 2000-04-27

Application number

NO20025107A

Other languages

English (en)

Other versions

NO20025107L (no

NO324250B1 (no

Inventor

Michael R Schrimpf

Karin R Tietje

Richard B Toupence

Jianguo Ji

Anwer Basha

William H Bunnelle

Jerome F Daanen

Jennifer M Pace

Kevin B Sippy

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-27

Filing date

2002-10-24

Publication date

2002-10-24

2001-04-12 Priority claimed from US09/833,914 external-priority patent/US6809105B2/en

2002-10-24 Application filed by Abbott Lab filed Critical Abbott Lab

2002-10-24 Publication of NO20025107D0 publication Critical patent/NO20025107D0/no

2002-12-19 Publication of NO20025107L publication Critical patent/NO20025107L/no

2007-09-17 Publication of NO324250B1 publication Critical patent/NO324250B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20025107A 2000-04-27 2002-10-24 Diazabicykliske forbindelser, farmasoytiske sammensetninger omfattende disse samt deres anvendelse NO324250B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US55994300A	2000-04-27	2000-04-27
US09/833,914 US6809105B2 (en)	2000-04-27	2001-04-12	Diazabicyclic central nervous system active agents
PCT/US2001/013798 WO2001081347A2 (en)	2000-04-27	2001-04-27	Diazabicyclic central nervous system active agents

Publications (3)

Publication Number	Publication Date
NO20025107D0 true NO20025107D0 (no)	2002-10-24
NO20025107L NO20025107L (no)	2002-12-19
NO324250B1 NO324250B1 (no)	2007-09-17

Family

ID=27072208

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20025107A NO324250B1 (no)	2000-04-27	2002-10-24	Diazabicykliske forbindelser, farmasoytiske sammensetninger omfattende disse samt deres anvendelse

Country Status (22)

Country	Link
EP (3)	EP2295437A1 (no)
JP (2)	JP4981232B2 (no)
KR (4)	KR100899950B1 (no)
CN (3)	CN100430398C (no)
AR (1)	AR030421A1 (no)
AU (2)	AU6655901A (no)
BG (2)	BG66151B1 (no)
BR (1)	BR0107246A (no)
CA (2)	CA2683045A1 (no)
CZ (4)	CZ302795B6 (no)
HK (1)	HK1054375A1 (no)
HU (1)	HUP0300602A3 (no)
IL (3)	IL152231A0 (no)
MX (1)	MXPA02010594A (no)
MY (3)	MY137020A (no)
NO (1)	NO324250B1 (no)
NZ (1)	NZ521734A (no)
PE (1)	PE20011305A1 (no)
PL (2)	PL358340A1 (no)
SK (2)	SK287658B6 (no)
TW (4)	TWI311137B (no)
WO (1)	WO2001081347A2 (no)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4078074B2 (ja)	1999-12-10	2008-04-23	ファイザー・プロダクツ・インク	ピロロ［２，３−ｄ］ピリミジン化合物
SE0100326D0 (sv) *	2001-02-02	2001-02-02	Astrazeneca Ab	New compounds
JP2006508976A (ja) *	2002-11-21	2006-03-16	ファイザー・プロダクツ・インク	３−アミノ−ピペラジン誘導体及び製造法
US20050261348A1 (en) *	2004-05-21	2005-11-24	Buckley Michael J	(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
US20040242641A1 (en)	2003-05-27	2004-12-02	Buckley Michael J.	(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
US7354937B2 (en)	2004-05-21	2008-04-08	Abbott Laboratories	(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
US20050043407A1 (en) *	2003-08-22	2005-02-24	Pfizer Inc	Pharmaceutical composition for the prevention and treatment of addiction in a mammal
US7399765B2 (en)	2003-09-19	2008-07-15	Abbott Laboratories	Substituted diazabicycloalkane derivatives
US20050065178A1 (en) *	2003-09-19	2005-03-24	Anwer Basha	Substituted diazabicycloakane derivatives
GB0322140D0 (en) *	2003-09-22	2003-10-22	Pfizer Ltd	Combinations
US8580842B2 (en)	2003-09-30	2013-11-12	Abbott Gmbh & Co. Kg	Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US20050171079A1 (en)	2004-02-04	2005-08-04	Schrimpf Michael R.	Amino-substituted tricyclic derivatives and methods of use
JP2007535553A (ja)	2004-04-29	2007-12-06	アボット・ラボラトリーズ	アミノ−テトラゾール類縁体および使用方法
US7351833B2 (en) *	2004-07-23	2008-04-01	Abbott Laboratories	(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
KR20080080206A (ko) *	2005-12-20	2008-09-02	아스트라제네카 아베	Ｇａｂａａ-수용체 조절제로서의 치환된 신놀린 유도체 및그의 합성 방법
US20070184490A1 (en) *	2006-01-17	2007-08-09	Marleen Verlinden	Neuronal nicotinic receptor ligands and their use
US7728031B2 (en)	2006-02-24	2010-06-01	Abbott Laboratories	Octahydro-pyrrolo[3,4-b]pyrrole derivatives
WO2008028903A2 (en)	2006-09-04	2008-03-13	Neurosearch A/S	Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
US20080167286A1 (en)	2006-12-12	2008-07-10	Abbott Laboratories	Pharmaceutical compositions and their methods of use
US8486979B2 (en)	2006-12-12	2013-07-16	Abbvie Inc.	1,2,4 oxadiazole compounds and methods of use thereof
US8076350B2 (en)	2006-12-22	2011-12-13	Abbott Laboratories	Spirocyclic azaadamantane derivatives and methods of use
UY30846A1 (es)	2006-12-30	2008-07-31	Abbott Gmbh & Amp	Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
CN101641355A (zh)	2007-03-23	2010-02-03	艾博特公司	氮杂金刚烷酯和氨基甲酸酯衍生物及其使用方法
WO2009036132A1 (en)	2007-09-11	2009-03-19	Abbott Laboratories	Octahydro-pyrrolo[3,4-b]pyrrole n-oxides
AR069126A1 (es)	2007-10-31	2009-12-30	Janssen Pharmaceutica Nv	Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa
CN101918409A (zh) *	2007-11-21	2010-12-15	雅培制药有限公司	联芳基取代的二氮杂双环烷衍生物
ES2455197T3 (es)	2007-12-07	2014-04-14	Abbvie Deutschland Gmbh & Co Kg	Derivados de oxindol 5,6-disustituidos y el uso de los mismos para la preparación de un medicamento para el tratamiento de enfermedades dependientes de vasopresina
WO2010009775A1 (de)	2007-12-07	2010-01-28	Abbott Gmbh & Co. Kg	Carbamat-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
CA2707667C (en)	2007-12-07	2016-02-23	Abbott Gmbh & Co. Kg	Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
BRPI0820668A2 (pt)	2007-12-07	2017-08-22	Abbott Gmbh & Co Kg	Derivados de oxindol substituídos por 5-halogênio e seu uso para tratar doenças dependentes de vasopressina
ES2380398T3 (es)	2007-12-18	2012-05-11	Actelion Pharmaceuticals Ltd.	Derivados 5-aminociclilmetil-oxazolidin-2-ona
SI2336125T1 (sl)	2008-04-11	2013-04-30	Janssen Pharmaceutica N.V.	Tiazolopiridin-2-iloksi-fenil in tiazolopirazin-2-iloksi-fenil amini kot modulatorji levkotrien a4 hidrolaze
US8148408B2 (en)	2008-05-09	2012-04-03	Abbott Laboratories	Selective substituted pyridine ligands for neuronal nicotinic receptors
WO2010111057A1 (en) *	2009-03-24	2010-09-30	Banyu Pharmaceutical Co., Ltd.	Novel aminopyridine derivatives having aurora a selective inhibitory action
CN102459251B (zh)	2009-05-14	2015-05-20	詹森药业有限公司	作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物
US9040568B2 (en)	2009-05-29	2015-05-26	Abbvie Inc.	Pharmaceutical compositions for the treatment of pain
WO2010151815A2 (en)	2009-06-25	2010-12-29	Abbott Laboratories	3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof
US8785440B2 (en)	2009-09-04	2014-07-22	Biogen Idec Ma, Inc.	Bruton's tyrosine kinase inhibitors
SI2491038T1 (sl)	2009-10-23	2016-08-31	Janssen Pharmaceutica N.V.	Disubstituirani oktahil-dropirolo(3,4-c)piroli kot modulatorji oreksinskega receptorja
JP5848251B2 (ja) *	2009-10-23	2016-01-27	ヤンセンファーマシューティカエヌ．ベー．	オレキシン受容体調節因子としての縮合複素環式化合物
WO2011050200A1 (en)	2009-10-23	2011-04-28	Janssen Pharmaceutica Nv	Fused heterocyclic compounds as orexin receptor modulators
WO2012145581A1 (en)	2011-04-20	2012-10-26	Janssen Pharmaceutica Nv	Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators
AR091273A1 (es)	2012-06-08	2015-01-21	Biogen Idec Inc	Inhibidores de pirimidinil tirosina quinasa
KR101655787B1 (ko)	2014-05-08	2016-09-22	대우조선해양 주식회사	선박의 하이브리드 공기조화시스템 및 그 방법, 그리고 이를 포함하는 선박 또는 해양구조물
KR20160021679A (ko)	2014-08-18	2016-02-26	대우조선해양 주식회사	극저온 환경의 장비용 히팅장치 및 방법 그리고 이를 구비하는 선박
KR20170090422A (ko)	2014-10-31	2017-08-07	인디비어 유케이 리미티드	도파민 d3 수용체 길항제 화합물
PH12018501903B1 (en)	2016-03-10	2023-03-17	Janssen Pharmaceutica Nv	Methods of treating depression using orexin-2 receptor antagonists
CN110049976A (zh)	2016-07-21	2019-07-23	比奥根Ma公司	布鲁顿氏酪氨酸激酶抑制剂的琥珀酸盐形式和组合物
CN109843872B (zh) *	2017-09-20	2022-08-30	杭州英创医药科技有限公司	作为ido抑制剂和/或ido-hdac双重抑制剂的多环化合物
GB201809295D0 (en)	2018-06-06	2018-07-25	Institute Of Cancer Res Royal Cancer Hospital	Lox inhibitors
SMT202400265T1 (it)	2018-11-14	2024-07-09	Janssen Pharmaceutica Nv	Metodi di sintesi migliorati per realizzare composti eterociclici fusi come modulatori del recettore per l'oressina
EP3978497A4 (en) *	2019-05-30	2022-07-13	Shanghai Institute of Materia Medica, Chinese Academy of Sciences	FUSED CYCLIC COMPOUND, METHOD FOR PREPARING IT AND ITS USE
CN112047878B (zh) *	2020-10-15	2022-04-19	郑州猫眼农业科技有限公司	4-溴-6-氯吡啶-2-羧酸的制备方法
WO2024189472A1 (en)	2023-03-14	2024-09-19	Janssen Pharmaceutica Nv	Improved synthetic methods of making substituted pyrimidine intermediates for synthesis of orexin receptor modulators

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0393424B1 (de)	1989-04-17	1995-09-27	Bayer Ag	Verfahren zur Herstellung von 2,7-Diazabicyclo(3.3.0)octanen
NL9201810A (nl)	1992-10-19	1994-05-16	Dsm Nv	Werkwijze voor de omzetting van een olefine of een olefinemengsel.
NO301165B1 (no)	1992-12-25	1997-09-22	Daiichi Seiyaku Co	Bicykliske aminderivater og antibakterielle midler inneholdende disse
US5817679A (en) *	1993-04-01	1998-10-06	University Of Virginia	7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
US5478939A (en) *	1994-07-20	1995-12-26	American Cyanamid Company	(R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives
US5472958A (en)	1994-08-29	1995-12-05	Abbott Laboratories	2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function
US5585388A (en)	1995-04-07	1996-12-17	Sibia Neurosciences, Inc.	Substituted pyridines useful as modulators of acetylcholine receptors
CA2227695C (en) *	1995-07-28	2008-02-12	Abbott Laboratories	Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
GB9519558D0 (en) *	1995-09-26	1995-11-29	Merck Sharp & Dohme	Therapeutic agents
JPH09172344A (ja)	1995-12-19	1997-06-30	Murata Mfg Co Ltd	圧電共振子
US5733912A (en)	1997-02-19	1998-03-31	Abbott Laboratories	7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
AU736798B2 (en) *	1997-05-30	2001-08-02	Neurosearch A/S	9-Azabicyclo(3.3.1)non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACh receptors
CN1157392C (zh) *	1997-05-30	2004-07-14	神经研究公司	在尼古丁ach受体上作为胆碱能配体的8-氮杂双环(3,2,1)辛-2-烯以及辛烷衍生物
GB9722343D0 (en) *	1997-10-22	1997-12-17	British Telecomm	Distributed virtual environment
EE04588B1 (et) *	1997-10-27	2006-02-15	Neurosearch A/S	Heteroarüüldiasatsükloalkaanid kui atsetüülkoliini nikotiinretseptorite kolinergilised ligandid, nende kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
US6632823B1 (en) *	1997-12-22	2003-10-14	Merck & Co., Inc.	Substituted pyridine compounds useful as modulators of acetylcholine receptors
JP2002510690A (ja) *	1998-04-02	2002-04-09	アール・ジェイ・レイノルズ・タバコ・カンパニー	アザトリシクロ［３．３．１．１］デカン誘導体とそれらを含有する薬剤組成物
PA8474101A1 (es) *	1998-06-19	2000-09-29	Pfizer Prod Inc	Compuestos de pirrolo [2,3-d] pirimidina
JP2000026408A (ja)	1998-07-02	2000-01-25	Dai Ichi Seiyaku Co Ltd	対掌体的に純粋なピロリジン誘導体、その塩、それらの製造方法
US6804251B1 (en)	1998-11-12	2004-10-12	Broadcom Corporation	System and method for multiplexing data from multiple sources
FR2786769B1 (fr) *	1998-12-04	2002-10-25	Synthelabo	Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
CZ20012716A3 (cs) *	1999-01-29	2001-11-14	Abbott Laboratories	Diazabicyklické deriváty jako ligandy nikotinového receptoru acetylcholinu
JP2002543201A (ja) *	1999-05-04	2002-12-17	ニューロサーチ、アクティーゼルスカブ	ヘテロアリールジアザビシクロアルカン類、その製造方法及びその使用方法
SI1178982T1 (en) *	1999-05-21	2004-12-31	Abbott Laboratories	Heterocyclic substituted aminoazacycles useful as central nervous system agents
US6815438B2 (en) *	1999-12-14	2004-11-09	Neurosearch A/S	Heteroaryl-diazabicycloalkanes

2001
- 2001-04-26 MY MYPI20011984A patent/MY137020A/en unknown
- 2001-04-26 MY MYPI20055633A patent/MY145722A/en unknown
- 2001-04-27 PL PL01358340A patent/PL358340A1/xx unknown
- 2001-04-27 CZ CZ20100538A patent/CZ302795B6/cs not_active IP Right Cessation
- 2001-04-27 MX MXPA02010594A patent/MXPA02010594A/es active IP Right Grant
- 2001-04-27 AU AU6655901A patent/AU6655901A/xx active Pending
- 2001-04-27 CZ CZ20090553A patent/CZ302038B6/cs not_active IP Right Cessation
- 2001-04-27 PL PL398491A patent/PL398491A1/pl unknown
- 2001-04-27 EP EP10177411A patent/EP2295437A1/en not_active Withdrawn
- 2001-04-27 SK SK10-2010A patent/SK287658B6/sk not_active IP Right Cessation
- 2001-04-27 AR ARP010101990A patent/AR030421A1/es active IP Right Grant
- 2001-04-27 AU AU2001266559A patent/AU2001266559C1/en not_active Ceased
- 2001-04-27 CZ CZ20080677A patent/CZ302072B6/cs not_active IP Right Cessation
- 2001-04-27 CN CNB018117112A patent/CN100430398C/zh not_active Expired - Fee Related
- 2001-04-27 EP EP01944118A patent/EP1284976A2/en not_active Withdrawn
- 2001-04-27 EP EP10177450A patent/EP2298775A1/en not_active Withdrawn
- 2001-04-27 CN CN2010102450796A patent/CN101935322A/zh active Pending
- 2001-04-27 SK SK1681-2002A patent/SK287273B6/sk not_active IP Right Cessation
- 2001-04-27 HK HK03104885.7A patent/HK1054375A1/zh unknown
- 2001-04-27 KR KR1020027014385A patent/KR100899950B1/ko not_active Expired - Fee Related
- 2001-04-27 CA CA002683045A patent/CA2683045A1/en not_active Abandoned
- 2001-04-27 WO PCT/US2001/013798 patent/WO2001081347A2/en not_active Ceased
- 2001-04-27 PE PE2001000385A patent/PE20011305A1/es not_active Application Discontinuation
- 2001-04-27 KR KR1020087031655A patent/KR100961406B1/ko not_active Expired - Fee Related
- 2001-04-27 IL IL15223101A patent/IL152231A0/xx not_active IP Right Cessation
- 2001-04-27 CZ CZ20023765A patent/CZ301324B6/cs not_active IP Right Cessation
- 2001-04-27 NZ NZ521734A patent/NZ521734A/en not_active IP Right Cessation
- 2001-04-27 KR KR1020097010331A patent/KR100947187B1/ko not_active Expired - Fee Related
- 2001-04-27 KR KR1020097021390A patent/KR100947188B1/ko not_active Expired - Fee Related
- 2001-04-27 CA CA002407094A patent/CA2407094C/en not_active Expired - Fee Related
- 2001-04-27 CN CN2012103509141A patent/CN102863441A/zh active Pending
- 2001-04-27 JP JP2001578437A patent/JP4981232B2/ja not_active Expired - Fee Related
- 2001-04-27 HU HU0300602A patent/HUP0300602A3/hu unknown
- 2001-04-27 BR BR0107246-3A patent/BR0107246A/pt not_active IP Right Cessation
- 2001-05-22 TW TW090110172A patent/TWI311137B/zh not_active IP Right Cessation
- 2001-05-22 TW TW097145362A patent/TWI357903B/zh not_active IP Right Cessation
- 2001-05-22 TW TW095100404A patent/TWI323733B/zh not_active IP Right Cessation
- 2001-05-22 TW TW100130949A patent/TW201141871A/zh unknown
2002
- 2002-10-24 NO NO20025107A patent/NO324250B1/no not_active IP Right Cessation
- 2002-11-21 BG BG107303A patent/BG66151B1/bg unknown
2005
- 2005-03-07 MY MYPI20094589A patent/MY168244A/en unknown
2006
- 2006-08-06 IL IL177316A patent/IL177316A/en not_active IP Right Cessation
2009
- 2009-12-29 IL IL203035A patent/IL203035A/en not_active IP Right Cessation
2010
- 2010-03-17 BG BG110620A patent/BG110620A/bg unknown
2011
- 2011-09-15 JP JP2011202172A patent/JP2012041349A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
CN100430398C (zh)	2008-11-05
MY137020A (en)	2008-12-31
HUP0300602A3 (en)	2005-12-28
WO2001081347A3 (en)	2002-01-31
BG107303A (bg)	2003-07-31
PL358340A1 (en)	2004-08-09
CN1440410A (zh)	2003-09-03
CZ302795B6 (cs)	2011-11-16
KR100947187B1 (ko)	2010-03-12
TW200617013A (en)	2006-06-01
NZ521734A (en)	2004-10-29
CZ302038B6 (cs)	2010-09-15
CZ302072B6 (cs)	2010-09-29
TW201141871A (en)	2011-12-01
SK287273B6 (sk)	2010-05-07
SK287658B6 (sk)	2011-05-06
CN101935322A (zh)	2011-01-05
CZ301324B6 (cs)	2010-01-13
CA2683045A1 (en)	2001-11-01
NO20025107L (no)	2002-12-19
TWI311137B (en)	2009-06-21
HK1054375A1 (zh)	2003-11-28
EP2298775A1 (en)	2011-03-23
IL177316A0 (en)	2006-12-10
CA2407094A1 (en)	2001-11-01
NO324250B1 (no)	2007-09-17
KR100899950B1 (ko)	2009-05-28
PL398491A1 (pl)	2012-06-04
KR20090121385A (ko)	2009-11-25
IL152231A0 (en)	2003-05-29
BG110620A (bg)	2010-07-30
AU2001266559C1 (en)	2005-11-17
EP2295437A1 (en)	2011-03-16
HUP0300602A2 (hu)	2003-06-28
EP1284976A2 (en)	2003-02-26
KR100947188B1 (ko)	2010-03-12
CA2407094C (en)	2009-11-17
PE20011305A1 (es)	2001-12-31
AR030421A1 (es)	2003-08-20
KR20020093955A (ko)	2002-12-16
MY145722A (en)	2012-03-30
CN102863441A (zh)	2013-01-09
SK16812002A3 (sk)	2003-04-01
MXPA02010594A (es)	2003-05-14
AU2001266559B2 (en)	2005-03-03
KR100961406B1 (ko)	2010-06-09
CZ20023765A3 (cs)	2003-02-12
KR20090013833A (ko)	2009-02-05
TWI323733B (en)	2010-04-21
KR20090071654A (ko)	2009-07-01
WO2001081347A2 (en)	2001-11-01
MY168244A (en)	2018-10-15
BR0107246A (pt)	2002-10-01
JP4981232B2 (ja)	2012-07-18
TWI357903B (en)	2012-02-11
JP2003531210A (ja)	2003-10-21
AU6655901A (en)	2001-11-07
IL177316A (en)	2010-06-30
IL203035A (en)	2010-12-30
JP2012041349A (ja)	2012-03-01
TW200909432A (en)	2009-03-01
BG66151B1 (bg)	2011-08-31

Publication	Publication Date	Title
NO20025107L (no)	2002-12-19	Diacabicykliske sentralnervesystemaktive midler
EP1296697A4 (en)	2005-02-16	Therapeutic agents - i
DE60125769D1 (de)	2007-02-15	Verbessertes elektroentionisierungssystem
DE60139338D1 (de)	2009-09-03	Bioprothetisches herzklappensystem
DE60131995D1 (de)	2008-01-31	Pestizid-abgabesystem
DK1335679T3 (da)	2009-06-29	Tandbörstningssystem
ATE391531T1 (de)	2008-04-15	Schweisshemmende mittel
PT1235558E (pt)	2006-09-29	Agentes terapeuticos
DE60126089D1 (de)	2007-03-08	Verabreichungssystem
NO20032390L (no)	2003-07-22	Serotonerge midler
DE60126237D1 (de)	2007-03-15	Fallstromverflüssiger
NO20030276L (no)	2003-03-18	Fremgangsmåte
ATE270043T1 (de)	2004-07-15	Fungizide wirkstoffkombinationen
DK1353910T3 (da)	2007-09-10	Lactamforbindelse
DE60135797D1 (de)	2008-10-30	Kunstleder
NO20031354L (no)	2003-05-02	Benzodiazepinderivater
DE60107105D1 (de)	2004-12-16	Sicherheitsgurtanordnung
DE60033231D1 (de)	2007-03-22	Personenrufanlage
DE59902159D1 (de)	2002-08-29	Aktiver mikromischer
DE60129123D1 (de)	2007-08-09	BIOLOGISCH AKTIVE 4H-BENZOi1,4öOXAZIN-3-ONE
DE50102084D1 (de)	2004-05-27	Hufschutz
NO20016301D0 (no)	2001-12-21	Terapeutiske midler
ATA4632000A (de)	2002-07-15	Verteilersystem
DE60131801D1 (de)	2008-01-24	Sprühfeuchtwerk
PT1318800E (pt)	2005-05-31	1-aminoalquilciclo-hexanos como agentes tripanocidas

Legal Events

Date	Code	Title	Description
2014-11-24	MM1K	Lapsed by not paying the annual fees